IceCure Medical Ltd (ICCM)
NASDAQ: ICCM · Real-Time Price · USD
0.2298
-0.0112 (-4.65%)
At close: May 15, 2026, 4:00 PM EDT
0.2255
-0.0043 (-1.87%)
After-hours: May 15, 2026, 7:42 PM EDT
IceCure Medical Revenue
IceCure Medical had revenue of $911.00K in the quarter ending March 31, 2026, with 25.66% growth. This brings the company's revenue in the last twelve months to $3.57M, up 8.92% year-over-year. In the year 2025, IceCure Medical had annual revenue of $3.38M with 2.67% growth.
Revenue (ttm)
$3.57M
Revenue Growth
+8.92%
P/S Ratio
5.23
Revenue / Employee
$51,667
Employees
69
Market Cap
18.66M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.38M | 88.00K | 2.67% |
| Dec 31, 2024 | 3.29M | 62.00K | 1.92% |
| Dec 31, 2023 | 3.23M | 144.00K | 4.67% |
| Dec 31, 2022 | 3.09M | -1.05M | -25.45% |
| Dec 31, 2021 | 4.14M | 270.00K | 6.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nortech Systems | 118.37M |
| IRIDEX | 52.68M |
| Trinity Biotech | 43.79M |
| Cytosorbents | 37.20M |
| Lifeward | 22.03M |
| Pulsenmore | 12.55M |
| Picard Medical | 4.94M |
| VolitionRx | 1.73M |
ICCM News
- 2 days ago - IceCure Medical price target lowered to $1 from $3 at Maxim - TheFly
- 2 days ago - IceCure Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement - PRNewsWire
- 4 days ago - IceCure Medical reports Q1 EPS (6c) vs. (6c) last year - TheFly
- 4 days ago - IceCure Medical Earnings Call Transcript: Q1 2026 - Transcripts
- 4 days ago - IceCure Reports First Quarter 2026 Financial Results: ProSense® Sales Increase Substantially in the U.S. and North America - PRNewsWire
- 10 days ago - IceCure Medical to Report First Quarter 2026 Financial and Operating Results on May 12, 2026 - PRNewsWire
- 11 days ago - IceCure Showcases ProSense® Cryoablation at American Society of Breast Surgeons 2026 Annual Meeting as Commercial Momentum Accelerates in the U.S. Market - PRNewsWire
- 12 days ago - IceCure Medical initiated with a Buy at Alliance Global - TheFly